TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹379 Cr | ₹156 Cr | ₹157 Cr | ₹151 Cr | ₹129 Cr |
What is the latest Contingent Liabilities ratio of TORRENT PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹379 Cr |
| Mar2025 | ₹156 Cr |
| Mar2024 | ₹157 Cr |
| Mar2023 | ₹151 Cr |
| Mar2022 | ₹129 Cr |
How is Contingent Liabilities of TORRENT PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹379 Cr | 142.92 | |
| Mar2025 | ₹156 Cr | -0.84 | |
| Mar2024 | ₹157 Cr | 4.38 | |
| Mar2023 | ₹151 Cr | 17.16 | |
| Mar2022 | ₹129 Cr | - | |
Compare Contingent Liabilities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹177,837.0 Cr | -1.8% | -4.8% | 32.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,483.0 Cr | -3.2% | -7.8% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹249,248.0 Cr | 1% | 0.9% | 67.8% | Stock Analytics | |
| CIPLA | ₹105,427.0 Cr | -3.1% | -6.5% | -12.2% | Stock Analytics | |
| MANKIND PHARMA | ₹99,064.7 Cr | -5.1% | 3.3% | 2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,492.3 Cr | -1.7% | 3.1% | -3.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -1.8% |
-4.8% |
32.2% |
| SENSEX | -1.2% |
-6.4% |
-10.8% |
You may also like the below Video Courses